Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

The survey highlights a preference for collaborative learning methods, with 75% of respondents favoring clinical case ...

Several districts across Nagaland observed World Diabetes Day on Thursday on the theme “Breaking barriers, bridging gaps.” ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

The long-term consequences of this metabolic dysfunction are extensive. (Image Credits: Pixabay) Diabetes risk and obesity: ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

In addition diabetes can be treated and its consequences avoided or delayed with medication, regular screening and treatment for complications. In 2007 General Assembly adopted resolution 61/225 ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...